32 studies found for:    " June 10, 2009":" July 10, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Active, not recruiting Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV
Conditions: Hepatitis B;   Hepatitis C;   HIV;   HIV Infections
Interventions: Behavioral: NCMIT;   Behavioral: SCMIT
2 Completed Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: Atripla
3 Completed
Has Results
A Safety Study to Evaluate the Antiviral Activity of Darunavir in Combination With Ritonavir in HIV 1 Infected Children
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir;   Drug: Ritonavir
4 Completed Study to Compare the Safety and Anti-HIV Effect of GSK1265744 Versus Placebo in HIV-1 Infected Adults (ITZ112929)
Condition: Acquired Immunodeficiency Syndrome
Interventions: Drug: GSK1265744;   Drug: Placebo
5 Unknown  Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)
Conditions: HIV;   Lung;   HIV Infections
Intervention: Behavioral: Smoking Cessation
6 Completed Effect of Extra Virgin Olive Oil on Atherosclerosis Biomarkers in HIV-infected Patients
Conditions: HIV;   Atherosclerosis;   HIV Infections
Interventions: Other: consumption 1. EVOO; 2. ROO;   Other: consumption 1. ROO; 2. EVOO
7 Active, not recruiting Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)
Conditions: HIV;   HIV Infections
Interventions: Drug: emtricitabine/tenofovir + lopinavir/ritonavir (WHO recommended second line);   Drug: abacavir + didanosine + lopinavir/ritonavir (WHO recommended second line);   Drug: emtricitabine/tenofovir + darunavir + ritonavir (Second line strategy under evaluation)
8 Completed HIV Viral Load Monitoring in Resource-Poor Settings
Conditions: HIV;   AIDS;   HIV Infections
Intervention: Other: HIV-1 viral load testing
9 Withdrawn Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial
Conditions: HIV Infection;   Pregnancy;   Breastfeeding;   HIV Infections
Interventions: Drug: Efavirenz-Tenofovir-Emtricitabine;   Drug: Zidovudine-Lamivudine-Lopinavir/Ritonavir
10 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
Condition: HIV Infection
Interventions: Drug: FTC/TDF;   Drug: Placebo
11 Completed Natural History Study of HIV Acquired in Infancy or Childhood
Condition: HIV Infections
Intervention:
12 Completed IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients
Condition: HIV Infections
Interventions: Drug: Isentress®;   Drug: Celsentri®
13 Completed CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery
Condition: HIV Infections
Intervention: Drug: Maraviroc
14 Completed Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya
Condition: HIV Infections
Intervention: Procedure: Integrated ANC, PMTCT, HIV services
15 Recruiting Comparing Daily vs Intermittent Regimen of ATT in HIV With Pulmonary Tuberculosis
Conditions: HIV Infection;   Pulmonary TB
Intervention: Drug: ATT (Ethambutol, Pyrazinamide, INH, Rifampicin)
16 Unknown  Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Conditions: Cervical Cancer Screening;   HIV Infections
Intervention:
17 Suspended Cognitive Rehabilitation in Ugandan Children With HIV
Condition: HIV Infections
Interventions: Behavioral: Computerized cognitive rehabilitation therapy (CCRT);   Behavioral: control group
18 Completed Study of Bone Disease in Older HIV-infected Adults
Conditions: Osteopenia;   Osteoporosis;   HIV Infection;   Aging;   HIV Infections
Intervention:
19 Terminated Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules
Conditions: HIV1 Infection;   HIV Infections
Intervention:
20 Completed
Has Results
Evaluation of Diagnostic HIV Ag/Ab Combo Assay
Condition: Human Immunodeficiency Viruses
Intervention: Device: ARCHITECT HIV Ag/Ab Combo

   Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results    Last Page
Indicates status has not been verified in more than two years